SERPINH1 expression tends to increase in patients with stage III–IV tumor, including BRCA, COAD, HNSC, CHOL, ESCA, LUSC, PAAD, LUAD, MESO, READ, SKCM, TGCT, UVM, STAD, and THCA. This evidence concerns the gene SERPINH1 and neoplasm.